A major step towards providing safe, effective and affordable biologics in Africa and beyond.
KIGALI, RWANDA AND SAN FRANCISCO, CALIFORNIA—FEB 9, 2024—
Bio Usawa Biotechnology Ltd announced that it has, in cooperation with the Rwanda Development Board, established its first subsidiary in Africa. This is aligned with Bio Usawa’ s vision of making Africa a manufacturing powerhouse and exporter of high-quality and affordable biologics. Bio Usawa shares the vision of African nations towards affordable, equitable healthcare that will have significant impact on human lives.

Dr. Bairu, CEO and co-founder of Bio Usawa, remarked, “the Bio Usawa team would like to express its appreciation for the rapid registration of Biousawa’ s accessory organization in Rwanda and applauds its collaboration with the Rwanda Development Board, its partners, and citizens of Rwanda for providing safe, effective and affordable biologics for people in Africa and beyond."

Dr Menghis Bairu, and TWIN Global member recently met Mr. Francis Gatare, Cabinet Member and CEO, Rwanda Development Board (RDB). Dr Gatare provided an overview of the Rwanda Development Board’s vision and priorities.

Dr Bairu shared Bio Usawa’ s vision of manufacturing quality lifesaving biologics for cancer, immunology, and ophthalmology in Africa, by Africans, for African and beyond.  Biousawa is also committed to developing and strengthening R&D capacities in Rwanda and other African nations by augmenting biologics research, manufacturing of biologics, strict quality control and by focusing on the solutions reaching the last mile through an equitable distribution supply chain system. Dr Menghis also discussed Bio Usawa’ s collaborations with the Rwanda Development Board for technology transfer and capacity building for end-to-end biologics development.

With the vision of transforming into a dynamic global hub for business, investment and innovation, the Rwanda Development Board, a premier institution of the Government of Rwanda, has established the Special Economic Zone (SEZ) and 9 Industrial parks in the country. The SEZ and the industrial park hub is designed to accelerate the supply of locally manufactured medical products including drugs, vaccines, and technologies to the domestic and global population. In addition, Rwanda has established a robust market access to African and global nations through well-structured free trade agreements.

Resources:
Manufacturing - Official Rwanda Development Board (RDB) Website
Bio Usawa Inc. | Home